As a formidable and known nucleoside analogue, Telbivudine is one of a few oral treatments to combat HBeAg positive and negative chronic hepatitis B. Known as the brand name Tyzeka, Telbivudine has a patent expiration of August 10, 2019. While the use of Telbivudine has been extremely successful in the United States, other countries around[…]
Telbivudine Makes Headlines in China for the Treatment of Hepatitis B
Antiviral, Patent Expiration 2019 Tags: Chinachronic hepatitis B Nov 05, 2013
Are Drospirenone and Estradiol the New Treatment for Post-Menopausal Women?
Hormonal Agent, Patent Expiration 2017 Tags: China Jan 30, 2013
Drospirenone is a key ingredient alongside Estradiol in the birth control pill Angeliq. The patent for Angeliq expires on August 11, 2017, making way for the development of generic options of this versatile hormone regulating medication. Developed as a birth control medication, used to prevent pregnancy, Angeliq works by preventing ovulation and causing changes in[…]
Gatifloxacin Is An Available and Effective Antibiotic
Antibiotic, Bulk Active Ingredient, Patent Expiration 2015, TEVA API Tags: antibioticChinaDNAophthalmic Sep 19, 2012
Gatifloxacin is a quinolone antibiotic also known as Tequin. While Tequin, which is marketed by Bristol- Myers Squibb is no longer sold as a tablet in the U.S., it is still sold in other countries in tablet form, like China. In the United States gatifloxacin is sold as an opthalmic solution, also known as Zymar,[…]